This suggests that direct and indirect targeting of MAT may represent a promising therapeutic strategy.398 Although demethylation and MAT-targeted strategies offer new perspectives for the treatment of pancreatic cancer, their clinical translation faces numerous challenges. This evidence concerns the gene MAT1A and familial pancreatic carcinoma.